Conatumumab (Anti-TNFRSF10B / TRAILR2 / CD262)

Conatumumab (Anti-TNFRSF10B / TRAILR2 / CD262) is a human monoclonal agonist antibody against human death receptor 5 (DR5, TRAILR2) with a Kd of 1 nM and 0.8 nM for the long form and the short form of DR5, respectively. Conatumumab induces apoptosis via caspase activation. MW : 144.96 KD.

• Supplier: Selleck Chemicals
• Product #: A2331
• Sku #: A2331-1mg*25